There was no evidence of clinically significant central adverse events, whereas drowsiness, dry mouth and nausea were reported with comparator agents (levodropropizine, codeine, DL-cloperastine).

The effects of levocloperastine - rapid reductions in the frequency and intensity of cough - were also observed in comparative trials with levodropropizine, codeine and DL-cloperastine.